Leo Pharma
Search results
Feb 16, 2024 · Since 1923, we have consistently devised and developed major advances for the treatment of allergy. In recent years, we have invested substantially in the research and development of new, evidence-based allergy immunotherapy treatments. Read more about ALK's history.
Jan 27, 2021 · The anaplastic lymphoma kinase (ALK) mutation is one of those gene changes. Knowing whether your cancer is ALK positive can help your doctor figure out which treatments will work best...
ALK-positive stands for Anaplastic Lymphoma Kinase Positive, or ALK+. It occurs in 1 out of 25 non-small-cell lung cancer (NSCLC) patients. Younger patients who have never smoked — usually 55 and under — are most likely to be diagnosed as being ALK+. How the ALK Mutation Works.
Feb 16, 2023 · Anaplastic lymphoma kinase (ALK) is a potent oncogenic driver in lung cancer. ALK tyrosine kinase inhibitors yield significant benefit in patients with ALK fusion-positive (ALK +) lung...
Discovered in 2007, “ALK-positive cancer” refers to the rearrangement of the EML4 gene and the ALK (anaplastic lymphoma kinase) gene in your DNA, resulting in a fusion oncogene EML4-ALK. An oncogene is a gene that is a mutated and may cause cancer cells.
Aug 30, 2019 · ALK is a global, research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies. OUR HISTORY. Nearly a century of leadership in allergy immunotherapy. Read more about ALK's rich history. OUR MILESTONES. Since 1923, we have consistently devised and developed major advances for the treatment of allergy.
Jun 8, 2021 · ALK non-small cell lung cancer happens when the anaplastic lymphoma kinase (ALK) gene mutates. Early diagnosis and treatment give people the best possible outlook.
